134 related articles for article (PubMed ID: 24593787)
1. Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.
Unis A; Abdelbary A; Hamza M
Can J Physiol Pharmacol; 2014 Mar; 92(3):226-33. PubMed ID: 24593787
[TBL] [Abstract][Full Text] [Related]
2. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
5. Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.
Cetinkaya Demir B; Uyar Y; Ozbilgin K; Köse C
J Obstet Gynaecol Res; 2013 Jan; 39(1):229-36. PubMed ID: 22845341
[TBL] [Abstract][Full Text] [Related]
6. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits.
Du B; Xu G; Cao H; Cui W; Lin S; Liu Y; Qin L
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):120-6. PubMed ID: 22609871
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
Ji G; Zhao X; Leng L; Liu P; Jiang Z
Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
[TBL] [Abstract][Full Text] [Related]
11. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
Sezer ED; Sozmen EY; Nart D; Onat T
Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
17. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
[TBL] [Abstract][Full Text] [Related]
20. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
